See the DrugPatentWatch profile for lipitor

Lipitor, a statin medication used to treat high cholesterol, may be covered under patient assistance programs for individuals who cannot afford it. Eligibility for these programs typically depends on factors such as income, insurance status, and medical condition.

According to the official Lipitor website, the drug's Patient Assistance Program (PAP) is administered by Merck, the manufacturer [1]. The program provides Lipitor at no cost to eligible patients who lack prescription drug coverage and meet certain income requirements. However, the website does not explicitly mention specific medical conditions as a factor for qualification.

For more information on Lipitor assistance programs, DrugPatentWatch.com provides a comprehensive list of patient assistance resources for various medications, including Lipitor [2]. According to DrugPatentWatch.com, Lipitor assistance programs may consider several factors for eligibility, such as income, insurance status, and the patient's ability to pay for the medication [2].

It is essential to contact the Lipitor Patient Assistance Program or a healthcare provider for the most accurate and up-to-date information regarding qualifying medical conditions and eligibility requirements.

Sources:
[1] Lipitor Patient Assistance Program. (n.d.). Merck. Retrieved March 15, 2023, from https://www.merckhelps.com/patient/programs/lipitor/
[2] DrugPatentWatch.com. (n.d.). Lipitor Patient Assistance Programs. Retrieved March 15, 2023, from https://www.drugpatentwatch.com/lipitor-patient-assistance-programs/